2014
DOI: 10.1016/j.ijpharm.2014.08.063
|View full text |Cite
|
Sign up to set email alerts
|

In vitro release testing methods for vitamin E nanoemulsions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(15 citation statements)
references
References 51 publications
0
12
0
1
Order By: Relevance
“…On the basis of previous studies, 25 an Agilent 1200 series HPLC system and a Finnigan LCQ Advantage ion-trap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an electrospray ionization source operating in positive ion mode were used for the analysis of plasma samples. Separation was achieved by isocratic elution using an Alltima C 18 column (250×4.6 mm, 5 μm), and the injection volume was 20 μL.…”
Section: Methodsmentioning
confidence: 99%
“…On the basis of previous studies, 25 an Agilent 1200 series HPLC system and a Finnigan LCQ Advantage ion-trap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an electrospray ionization source operating in positive ion mode were used for the analysis of plasma samples. Separation was achieved by isocratic elution using an Alltima C 18 column (250×4.6 mm, 5 μm), and the injection volume was 20 μL.…”
Section: Methodsmentioning
confidence: 99%
“…NE was fabricated by wash-out method [12] . In this method, water phase wasadded continuously to the mixture of oil phase (mustard oil), surfactant (tween-80) and the functional compound (Vitamin E acetate).…”
Section: Preparation Of Nanoemulsionmentioning
confidence: 99%
“…The droplet diameter greatly affects the in vitro release capacity from the dispersed to continuous phases [12] . The average diameter for formulated NE (z-average) was found to be 86.45 ± 3.61 nm with the polydispersivity index (PDI) as 0.391 ± 0.43.…”
Section: Droplet Size Distribution and Zeta Potentialmentioning
confidence: 99%
“…According to the lower release amount and slower release rate of RA from NLC and NE compared to the solution, it could be remarked that both of them exhibited a controlled release pattern. The prolonged release of RA from NE was suggested to result from the rate-limiting step of RA diffusion across the interfacial film between the internal and external phases of NE [9,50], whereas the prolonged release of RA from NLC resulted from the Fickian diffusion of RA throughout the lipid matrix of NLC [51]. The release profiles of NLC can vary from very fast release, medium release, or extremely prolonged release depending on the matrix structure, the method of production, the solubilizing properties of the surfactant for the incorporated active, and the solubility of the active in the lipid matrix [52].…”
Section: In Vitro Release Profile Of Dermal Delivery System Containinmentioning
confidence: 99%